ESC Webinar Series - Diabetes. Focus on the evidence for SGLT2i in the prevention and treatment of heart failure. SGLT2i – A new class of drugs for the treatment of heart failure.

Event : Webinar 2020

• Session : HFA Webinars 2020
• Speaker : GMC Rosano (London,GB), M Metra (Brescia,IT), M Petrie (Glasgow,GB)

ESC Webinars Series - Diabetes. Focus 2: SGLT2 Inhibitors - New data and guidelines change practice.

Event : Webinar 2020

• Session : ESC Webinars 2020
• Speaker : O Mosenzon (Jerusalem,IL), M Petrie (Glasgow,GB), GMC Rosano (London,GB)

Exploring the link between type 2 diabetes and cardiovascular disease.

Event : ESC Congress 2020

• Session : The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care
• Speaker : M Petrie (Glasgow,GB)

• Sponsored by Novo Nordisk A/S

Panel discussion.

Event : ESC Congress 2020

• Session : The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care
• Speaker : M Petrie (Glasgow,GB), S Verma (Toronto,CA), M Kosiborod (Kansas,US)

• Sponsored by Novo Nordisk A/S

SGLT2 inhibition: Making waves in the heart failure landscape.

Event : HFA Discoveries 2020

• Session : SGLT2 inhibition: Making waves in the heart failure landscape
• Speaker : CS Lam (Singapore,SG), J Butler (Atlanta,US), M Petrie (Glasgow,GB), GMC Rosano (London,GB)

• Organised by CHANGE IME in partnership with Leicester Diabetes Centre

Welcome and introduction.

Event : ESC Congress 2020

• Session : The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care
• Speaker : M Petrie (Glasgow,GB)

• Sponsored by Novo Nordisk A/S

Clinical phenotype and outcomes.

Event : Heart Failure 2019

• Session : Peripartum cardiomyopathy: new clinical insights
• Speaker : M Petrie (Glasgow,GB)

How to implement the guidelines.

Event : Heart Failure 2019

• Session : Guidelines in Daily Practice III: Myocardial revascularisation in heart failure
• Speaker : M Petrie (Glasgow,GB)

Coronary and valvular interventions

Event : Heart Failure 2018

• Session : Acute heart failure - When drugs alone are not enough
• Speaker : M Petrie (Glasgow,GB)

Mitral and tricuspid interventions

Event : Heart Failure 2018

• Session : Interventional heart failure therapies - Are we there yet?
• Speaker : M Petrie (Glasgow,GB)

Tricuspid regurgitation

Event : Heart Failure 2018

• Session : Management of valvular heart disease in heart failure - Drugs, intervention or surgery?
• Speaker : M Petrie (Glasgow,GB)

STICH – The best revascularisation strategy in ischaemic cardiomyopathy is… ?

Event : Heart Failure 2017

• Session : How the results of recent randomized clinical trials will impact our practice
• Speaker : M Petrie (Glasgow,GB)

PCI in heart failure - Putting it all together.

Event : Heart Failure 2016

• Session : Revascularisation strategies in ischemic heart failure
• Speaker : M Petrie (Glasgow,GB)

Mechanisms of action and comparative efficacy of the novel vasodilator apelin

Event : Heart Failure 2015

• Session : Basic Science: Neuroendocrine activation and receptor pharmacology
• Speaker : M Petrie (Glasgow,GB)

PPCM case

Event : ESC Congress 2015

• Session : Pregnancy and heart failure
• Speaker : M Petrie (Glasgow,GB)

Subsequent pregnancy and long-term prognosis.

Event : ESC Congress 2014

• Session : Update in peripartum cardiomyopathy
• Speaker : M Petrie (Glasgow,GB)

Risk associated with subsequent pregnancy.

Event : ESC Congress 2013

• Session : Controversies in peripartum cardiomyopathy
• Speaker : M Petrie (Glasgow,GB)